Share Price and Basic Stock Data
Last Updated: February 3, 2026, 3:35 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Oxygen Investments Ltd operates as a non-banking financial company (NBFC) with a current market capitalization of ₹305 Cr. The company’s stock is priced at ₹20,307. Revenue trends indicate significant fluctuations, with reported revenue of ₹17.45 Cr in September 2022, declining to ₹7.13 Cr in December 2022, and further suffering a loss of ₹6.47 Cr in March 2023. However, a rebound was observed in subsequent quarters, with revenue rising to ₹21.80 Cr in June 2023 and ₹14.07 Cr in September 2023. The revenue peaked at ₹22.32 Cr in December 2023 before experiencing another decline to ₹12.66 Cr in March 2024. This revenue volatility reflects the underlying operational challenges faced by the company, as indicated by a trailing twelve-month revenue figure of ₹-9.57 Cr. Despite these challenges, the company has not reported any borrowings, which may provide some leverage during turbulent times.
Profitability and Efficiency Metrics
Profitability metrics for Bombay Oxygen Investments Ltd reveal a complex picture, with the net profit recorded at ₹-8.77 Cr. The company has experienced substantial fluctuations in net profit, with positive figures such as ₹19.57 Cr in June 2023 and ₹11.86 Cr in September 2023, contrasting with losses of ₹2.16 Cr in March 2023 and ₹15.48 Cr in December 2024. Operating profit margin (OPM) figures are notably absent, indicating challenges in maintaining operational efficiency. Return on equity (ROE) stood at 3.62%, while return on capital employed (ROCE) was slightly higher at 3.89%, both of which are significantly lower compared to typical sector benchmarks. The cash conversion cycle (CCC) was reported at 8 days, suggesting efficient management of cash flows, although the overall profitability remains a concern. The earnings yield was reported at a meager 0.05%, highlighting the company’s struggle to generate significant returns for investors.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Oxygen Investments Ltd exhibits a robust structure with no borrowings and total reserves amounting to ₹513.07 Cr. The absence of debt is a notable strength, positioning the company favorably against financial stress. The price-to-book value (P/BV) ratio was recorded at 0.68x, indicating that the stock may be undervalued relative to its book value. Furthermore, the company’s current ratio stood at an impressive 2464.27, signifying strong liquidity and the ability to cover short-term obligations. However, the asset turnover ratio of 0.04% suggests that the company is not efficiently utilizing its assets to generate revenue. The enterprise value (EV) to net operating revenue ratio was reported at 16.39, indicating a high valuation relative to operating revenue, which may deter potential investors. Overall, while the balance sheet reflects strength in liquidity and debt management, operational efficiency remains a critical area for improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bombay Oxygen Investments Ltd reveals a strong promoter presence, holding 73.29% of the shares, which has remained stable across reporting periods. This significant promoter stake reflects confidence in the company’s long-term prospects. Conversely, institutional investors have minimal involvement, with domestic institutional investors (DIIs) holding just 0.06%. Public ownership stands at 26.66%, indicating a moderate level of retail investor participation, with a total of 3,039 shareholders reported. The gradual increase in the number of shareholders from 2,880 in September 2023 to 3,039 in September 2025 suggests growing interest from the retail segment. However, the lack of foreign institutional investment (FIIs) may raise concerns regarding broader market confidence. The stability in promoter holdings, along with a slight increase in public interest, could indicate potential for future growth, provided operational performance improves.
Outlook, Risks, and Final Insight
The outlook for Bombay Oxygen Investments Ltd hinges on its ability to stabilize revenue and profitability metrics, which have shown considerable volatility. The absence of borrowings offers a cushion against financial distress, but the company must address its operational inefficiencies to enhance profitability. Key risks include the inconsistent revenue streams, as demonstrated by the drastic revenue fluctuations, and the reported net losses which could impact investor sentiment. Furthermore, the low ROE and ROCE figures raise concerns about the company’s efficiency in generating returns. On the positive side, the strong promoter backing and healthy liquidity position could serve as a foundation for recovery. Overall, while the company faces significant challenges, a focused strategy on enhancing operational performance and attracting institutional interest could pave the way for a more favorable market position in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 15.3 Cr. | 1.53 | 1.66/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 6.63 Cr. | 0.66 | 5.29/0.62 | 19.5 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 349 Cr. | 53.3 | 125/44.0 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 13.9 Cr. | 15.1 | 25.5/14.8 | 11.5 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 27.5 Cr. | 61.1 | 146/57.6 | 14.9 | 238 | 1.64 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,891.29 Cr | 392.12 | 52.51 | 514.98 | 0.24% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.45 | 7.13 | -6.47 | 21.80 | 14.07 | 22.32 | 12.66 | 29.01 | 23.97 | -18.54 | -14.22 | 28.89 | -5.70 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Expenses | 0.42 | 0.42 | 0.43 | 0.41 | 0.39 | 0.40 | 0.62 | 0.42 | 0.39 | 0.38 | 0.45 | 0.40 | 0.42 |
| Financing Profit | 17.03 | 6.71 | -6.90 | 21.39 | 13.68 | 21.92 | 12.04 | 28.59 | 23.58 | -18.92 | -14.67 | 28.49 | -6.12 |
| Financing Margin % | 97.59% | 94.11% | 106.65% | 98.12% | 97.23% | 98.21% | 95.10% | 98.55% | 98.37% | 102.05% | 103.16% | 98.62% | 107.37% |
| Other Income | 0.05 | -0.00 | 4.22 | -0.00 | -0.00 | 0.01 | 1.37 | -0.00 | -0.00 | 0.69 | -0.00 | -0.00 | -0.00 |
| Depreciation | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 |
| Profit before tax | 17.04 | 6.66 | -2.73 | 21.34 | 13.63 | 21.88 | 13.36 | 28.54 | 23.53 | -18.27 | -14.72 | 28.44 | -6.17 |
| Tax % | 10.33% | 9.76% | -21.25% | 8.29% | 12.99% | 20.16% | 34.96% | 5.96% | 21.59% | -15.33% | -16.44% | 14.84% | -15.24% |
| Net Profit | 15.28 | 6.02 | -2.16 | 19.57 | 11.86 | 17.47 | 8.69 | 26.84 | 18.45 | -15.48 | -12.30 | 24.23 | -5.22 |
| EPS in Rs | 1,018.67 | 401.33 | -144.00 | 1,304.67 | 790.67 | 1,164.67 | 579.33 | 1,789.33 | 1,230.00 | -1,032.00 | -820.00 | 1,615.33 | -348.00 |
| Gross NPA % | |||||||||||||
| Net NPA % |
Last Updated: February 2, 2026, 7:16 pm
Below is a detailed analysis of the quarterly data for Bombay Oxygen Investments Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Jun 2025) to 0.42 Cr., marking an increase of 0.02 Cr..
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is -6.17 Cr.. The value appears to be declining and may need further review. It has decreased from 28.44 Cr. (Jun 2025) to -6.17 Cr., marking a decrease of 34.61 Cr..
- For Tax %, as of Sep 2025, the value is -15.24%. The value appears to be improving (decreasing) as expected. It has decreased from 14.84% (Jun 2025) to -15.24%, marking a decrease of 30.08%.
- For Net Profit, as of Sep 2025, the value is -5.22 Cr.. The value appears to be declining and may need further review. It has decreased from 24.23 Cr. (Jun 2025) to -5.22 Cr., marking a decrease of 29.45 Cr..
- For EPS in Rs, as of Sep 2025, the value is -348.00. The value appears to be declining and may need further review. It has decreased from 1,615.33 (Jun 2025) to -348.00, marking a decrease of 1,963.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.97 | 17.30 | 17.55 | 1.50 | 1.56 | 11.40 | 2.47 | 60.92 | 33.35 | 2.62 | 72.22 | 20.21 | -9.57 |
| Expenses | 23.64 | 23.70 | 24.47 | 7.25 | 12.52 | 3.68 | 24.71 | 2.07 | 1.89 | 1.67 | 1.80 | 1.63 | 1.65 |
| Operating Profit | -4.67 | -6.40 | -6.92 | -5.75 | -10.96 | 7.72 | -22.24 | 58.85 | 31.46 | 0.95 | 70.42 | 18.58 | -11.22 |
| OPM % | -24.62% | -36.99% | -39.43% | -383.33% | -702.56% | 67.72% | -900.40% | 96.60% | 94.33% | 36.26% | 97.51% | 91.93% | 117.24% |
| Other Income | 5.41 | 20.39 | 9.40 | 14.18 | 13.00 | -1.33 | 2.40 | 6.79 | 0.29 | 4.26 | 0.00 | 0.69 | 0.69 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 3.46 | 2.58 | 2.96 | 0.26 | 0.21 | 0.29 | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Profit before tax | -2.72 | 11.41 | -0.48 | 8.17 | 1.83 | 6.10 | -20.04 | 65.45 | 31.56 | 5.02 | 70.23 | 19.08 | -10.72 |
| Tax % | -1.84% | 32.52% | -179.17% | 23.87% | 24.59% | -11.64% | -1.60% | 10.94% | 11.06% | 1.79% | 17.97% | 8.23% | |
| Net Profit | -2.68 | 7.70 | 0.38 | 6.23 | 1.38 | 6.81 | -19.72 | 58.29 | 28.07 | 4.92 | 57.60 | 17.51 | -8.77 |
| EPS in Rs | -178.67 | 513.33 | 25.33 | 415.33 | 92.00 | 454.00 | -1,314.67 | 3,886.00 | 1,871.33 | 328.00 | 3,840.00 | 1,167.33 | -584.67 |
| Dividend Payout % | 0.00% | 1.95% | 39.47% | 4.82% | 10.87% | 2.20% | -0.76% | 0.51% | 1.07% | 4.57% | 0.65% | 3.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 387.31% | -95.06% | 1539.47% | -77.85% | 393.48% | -389.57% | 395.59% | -51.84% | -82.47% | 1070.73% | -69.60% |
| Change in YoY Net Profit Growth (%) | 0.00% | -482.38% | 1634.54% | -1617.32% | 471.33% | -783.05% | 785.16% | -447.43% | -30.63% | 1153.20% | -1140.33% |
Bombay Oxygen Investments Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 52% |
| 3 Years: | -15% |
| TTM: | -74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 23% |
| 3 Years: | -15% |
| TTM: | -77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 28% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: February 1, 2026, 2:29 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Reserves | 190.44 | 197.61 | 197.80 | 217.25 | 208.82 | 219.60 | 172.10 | 300.63 | 324.35 | 331.23 | 461.17 | 481.57 | 513.07 |
| Borrowing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 11.07 | 13.06 | 11.86 | 17.44 | 5.69 | 5.14 | 1.31 | 10.23 | 11.97 | 13.44 | 31.11 | 25.85 | 30.92 |
| Total Liabilities | 203.01 | 212.17 | 211.16 | 236.19 | 216.01 | 226.24 | 174.91 | 312.36 | 337.82 | 346.17 | 493.78 | 508.92 | 545.49 |
| Fixed Assets | 37.82 | 35.16 | 32.26 | 29.40 | 8.45 | 7.82 | 7.49 | 7.25 | 7.04 | 7.12 | 6.93 | 6.70 | 6.61 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 68.24 | 164.76 | 165.93 | 196.06 | 195.41 | 209.82 | 158.38 | 296.75 | 324.19 | 332.55 | 485.69 | 500.82 | 537.40 |
| Other Assets | 96.95 | 12.25 | 12.97 | 10.73 | 12.15 | 8.60 | 9.04 | 8.36 | 6.59 | 6.50 | 1.16 | 1.40 | 1.48 |
| Total Assets | 203.01 | 212.17 | 211.16 | 236.19 | 216.01 | 226.24 | 174.91 | 312.36 | 337.82 | 346.17 | 493.78 | 508.92 | 545.49 |
Below is a detailed analysis of the balance sheet data for Bombay Oxygen Investments Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 1.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.50 Cr..
- For Reserves, as of Sep 2025, the value is 513.07 Cr.. The value appears strong and on an upward trend. It has increased from 481.57 Cr. (Mar 2025) to 513.07 Cr., marking an increase of 31.50 Cr..
- For Other Liabilities, as of Sep 2025, the value is 30.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.85 Cr. (Mar 2025) to 30.92 Cr., marking an increase of 5.07 Cr..
- For Total Liabilities, as of Sep 2025, the value is 545.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 508.92 Cr. (Mar 2025) to 545.49 Cr., marking an increase of 36.57 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.61 Cr.. The value appears to be declining and may need further review. It has decreased from 6.70 Cr. (Mar 2025) to 6.61 Cr., marking a decrease of 0.09 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 537.40 Cr.. The value appears strong and on an upward trend. It has increased from 500.82 Cr. (Mar 2025) to 537.40 Cr., marking an increase of 36.58 Cr..
- For Other Assets, as of Sep 2025, the value is 1.48 Cr.. The value appears strong and on an upward trend. It has increased from 1.40 Cr. (Mar 2025) to 1.48 Cr., marking an increase of 0.08 Cr..
- For Total Assets, as of Sep 2025, the value is 545.49 Cr.. The value appears strong and on an upward trend. It has increased from 508.92 Cr. (Mar 2025) to 545.49 Cr., marking an increase of 36.57 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.67 | -6.40 | -6.92 | -5.75 | -10.96 | 7.72 | -22.24 | 58.85 | 31.46 | 0.95 | 70.42 | 18.58 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 98 | 84 | 75 | 326 | 44 | 19 | 71 | 3 | 5 | 65 | 2 | 8 |
| Inventory Days | 851 | 584 | 734 | 2 | 5 | |||||||
| Days Payable | 620 | 407 | 195 | 104 | 167 | |||||||
| Cash Conversion Cycle | 98 | 315 | 252 | 864 | -58 | -143 | 71 | 3 | 5 | 65 | 2 | 8 |
| Working Capital Days | 972 | 93 | 86 | 1,472 | -592 | 44 | 748 | 29 | 62 | 828 | 3 | 15 |
| ROCE % | -2% | 8% | -5% | 3% | -2% | 3% | -11% | 25% | 10% | 0% | 18% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Basic EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Diluted EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Cash EPS (Rs.) | 1179.98 | 3853.00 | 340.84 | 1883.90 | 3898.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Dividend / Share (Rs.) | 35.00 | 25.00 | 15.00 | 20.00 | 20.00 |
| Revenue From Operations / Share (Rs.) | 1347.54 | 4722.64 | 174.53 | 2223.11 | 4061.41 |
| PBDIT / Share (Rs.) | 1284.68 | 4694.34 | 347.17 | 2116.54 | 4376.25 |
| PBIT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| PBT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| Net Profit / Share (Rs.) | 1167.06 | 3840.06 | 328.30 | 1871.22 | 3885.80 |
| PBDIT Margin (%) | 95.33 | 99.40 | 198.91 | 95.20 | 107.75 |
| PBIT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| PBT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| Net Profit Margin (%) | 86.60 | 81.31 | 188.10 | 84.17 | 95.67 |
| Return on Networth / Equity (%) | 3.62 | 12.44 | 1.48 | 8.61 | 19.29 |
| Return on Capital Employeed (%) | 3.74 | 14.22 | 1.45 | 9.34 | 20.99 |
| Return On Assets (%) | 3.43 | 11.66 | 1.42 | 8.30 | 18.66 |
| Asset Turnover Ratio (%) | 0.04 | 0.16 | 0.01 | 0.10 | 0.25 |
| Current Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Quick Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Dividend Payout Ratio (NP) (%) | 2.14 | 0.39 | 6.09 | 1.06 | 0.25 |
| Dividend Payout Ratio (CP) (%) | 2.11 | 0.38 | 5.86 | 1.06 | 0.25 |
| Earning Retention Ratio (%) | 97.86 | 99.61 | 93.91 | 98.94 | 99.75 |
| Cash Earning Retention Ratio (%) | 97.89 | 99.62 | 94.14 | 98.94 | 99.75 |
| Enterprise Value (Cr.) | 331.29 | 265.65 | 154.11 | 194.17 | 163.13 |
| EV / Net Operating Revenue (X) | 16.39 | 3.75 | 58.87 | 5.82 | 2.68 |
| EV / EBITDA (X) | 17.19 | 3.77 | 29.59 | 6.12 | 2.48 |
| MarketCap / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| Retention Ratios (%) | 97.85 | 99.60 | 93.90 | 98.93 | 99.74 |
| Price / BV (X) | 0.68 | 0.57 | 0.46 | 0.59 | 0.54 |
| Price / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| EarningsYield | 0.05 | 0.21 | 0.03 | 0.14 | 0.35 |
After reviewing the key financial ratios for Bombay Oxygen Investments Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 100.00. This value exceeds the healthy maximum of 10. There is no change compared to the previous period (Mar 24) which recorded 100.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Cash EPS (Rs.), as of Mar 25, the value is 1,179.98. This value is within the healthy range. It has decreased from 3,853.00 (Mar 24) to 1,179.98, marking a decrease of 2,673.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Dividend / Share (Rs.), as of Mar 25, the value is 35.00. This value exceeds the healthy maximum of 3. It has increased from 25.00 (Mar 24) to 35.00, marking an increase of 10.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,347.54. It has decreased from 4,722.64 (Mar 24) to 1,347.54, marking a decrease of 3,375.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1,284.68. This value is within the healthy range. It has decreased from 4,694.34 (Mar 24) to 1,284.68, marking a decrease of 3,409.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For PBDIT Margin (%), as of Mar 25, the value is 95.33. This value is within the healthy range. It has decreased from 99.40 (Mar 24) to 95.33, marking a decrease of 4.07.
- For PBIT Margin (%), as of Mar 25, the value is 94.37. This value exceeds the healthy maximum of 20. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For PBT Margin (%), as of Mar 25, the value is 94.37. This value is within the healthy range. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For Net Profit Margin (%), as of Mar 25, the value is 86.60. This value exceeds the healthy maximum of 10. It has increased from 81.31 (Mar 24) to 86.60, marking an increase of 5.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 15. It has decreased from 12.44 (Mar 24) to 3.62, marking a decrease of 8.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.74. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to 3.74, marking a decrease of 10.48.
- For Return On Assets (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 5. It has decreased from 11.66 (Mar 24) to 3.43, marking a decrease of 8.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has decreased from 0.16 (Mar 24) to 0.04, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 3. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Quick Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 2. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 20. It has increased from 0.39 (Mar 24) to 2.14, marking an increase of 1.75.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.11. This value is below the healthy minimum of 20. It has increased from 0.38 (Mar 24) to 2.11, marking an increase of 1.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 97.86. This value exceeds the healthy maximum of 70. It has decreased from 99.61 (Mar 24) to 97.86, marking a decrease of 1.75.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.89. This value exceeds the healthy maximum of 70. It has decreased from 99.62 (Mar 24) to 97.89, marking a decrease of 1.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 331.29. It has increased from 265.65 (Mar 24) to 331.29, marking an increase of 65.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 16.39. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.39, marking an increase of 12.64.
- For EV / EBITDA (X), as of Mar 25, the value is 17.19. This value exceeds the healthy maximum of 15. It has increased from 3.77 (Mar 24) to 17.19, marking an increase of 13.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For Retention Ratios (%), as of Mar 25, the value is 97.85. This value exceeds the healthy maximum of 70. It has decreased from 99.60 (Mar 24) to 97.85, marking a decrease of 1.75.
- For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.68, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.21 (Mar 24) to 0.05, marking a decrease of 0.16.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Oxygen Investments Ltd:
- Net Profit Margin: 86.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.74% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.62% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2464.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 52.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 86.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 22/B, Mittal Tower, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shyam M Ruia | Chairman |
| Ms. Hema Renganathan | Whole Time Director |
| Mr. Vikas M Jain | Non Exe.Non Ind.Director |
| Mrs. Sudha Navin Shetty | Independent Director |
| Mr. Suresh Sitaram Sigtia | Independent Director |
| Mr. Krishna Kumar Kunwar | Independent Director |
FAQ
What is the intrinsic value of Bombay Oxygen Investments Ltd?
Bombay Oxygen Investments Ltd's intrinsic value (as of 05 February 2026) is ₹3748.85 which is 81.54% lower the current market price of ₹20,307.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹305 Cr. market cap, FY2025-2026 high/low of ₹31,998/19,200, reserves of ₹513.07 Cr, and liabilities of ₹545.49 Cr.
What is the Market Cap of Bombay Oxygen Investments Ltd?
The Market Cap of Bombay Oxygen Investments Ltd is 305 Cr..
What is the current Stock Price of Bombay Oxygen Investments Ltd as on 05 February 2026?
The current stock price of Bombay Oxygen Investments Ltd as on 05 February 2026 is ₹20,307.
What is the High / Low of Bombay Oxygen Investments Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Oxygen Investments Ltd stocks is ₹31,998/19,200.
What is the Stock P/E of Bombay Oxygen Investments Ltd?
The Stock P/E of Bombay Oxygen Investments Ltd is .
What is the Book Value of Bombay Oxygen Investments Ltd?
The Book Value of Bombay Oxygen Investments Ltd is 34,305.
What is the Dividend Yield of Bombay Oxygen Investments Ltd?
The Dividend Yield of Bombay Oxygen Investments Ltd is 0.17 %.
What is the ROCE of Bombay Oxygen Investments Ltd?
The ROCE of Bombay Oxygen Investments Ltd is 3.89 %.
What is the ROE of Bombay Oxygen Investments Ltd?
The ROE of Bombay Oxygen Investments Ltd is 3.62 %.
What is the Face Value of Bombay Oxygen Investments Ltd?
The Face Value of Bombay Oxygen Investments Ltd is 100.